Metraipolis › archive › dc_34bfe1eb5ce6

Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A… — Europe PMC PMID:41702836

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41702836
DOI
10.1002/cam4.71637
License (as archived)
solo-consultazione
Archived
2026-11-06T08:55:55.086Z
SHA-256 of the archived text
dc569f9947ef11e46ec96d52ea4beadd61e3aaa856f57e3a78b1063bf6da1216
Stable URL of this page
https://metraipolis.com/documento/dc_34bfe1eb5ce6

How to cite

Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A… — Europe PMC PMID:41702836 — Europe PMC (en), https://europepmc.org/article/MED/41702836 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34bfe1eb5ce6 (Metraipolis archive dc_34bfe1eb5ce6, sha256 dc569f9947ef11e46ec96d52ea4beadd61e3aaa856f57e3a78b1063bf6da1216)
BibTeX
@misc{dc34bfe1eb5ce6,
  title = {Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A… — Europe PMC PMID:41702836},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41702836},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34bfe1eb5ce6; sha256 dc569f9947ef11e46ec96d52ea4beadd61e3aaa856f57e3a78b1063bf6da1216},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41702836. Agents can read the archived copy with the MCP tool read_document.